Northwest Biotherapeutics share price logo

Northwest Biotherapeutics

OTC: NWBO

Small Cap

$0.17

(+-1.28%)

as on

Northwest Biotherapeutics Stock Performance

as on September 2, 2026 at 6:59 am IST

  • $0.17
    $0.17
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Northwest Biotherapeutics share price movements today

Previous Close
$0.17
Open
$0.17
Volume
5.1M
Market Cap
$290.0M
Day's Low - High
$0.17 - $0.17

Northwest Biotherapeutics Historical Returns

1 Month Return
+ 2.44 %
3 Month Return
-18.05 %
1 Year Return
-36.6 %
3 Year Return
-70.53 %
5 Year Return
0 %

Northwest Biotherapeutics Stock Fundamentals & Key Indicators

Check Northwest Biotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$290.0M

EPS (TTM)

-0.0249

Dividend Yield

0.00%

PE Ratio (TTM)

-7.01

Industry PE ratio

-6.724375

PEG Ratio

-0.07097821490300468

Return On Equity TTM

69.98%

Northwest Biotherapeutics Stock Valuation

Track how Northwest Biotherapeutics P/E has moved over time to understand its valuation trends.

Northwest Biotherapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-12.61x)

December 31, 2023

Industry (-6.72x)

December 31, 2025

Today (-5.39x)

December 31, 2025

Highest (3.41x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -5.39x

Northwest Biotherapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Northwest Biotherapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$290.0MNA-7.01-39.02%NA
BUY$44.6B614.61%NA0.00%NA
BUY$137.9B174.9%31.9286.04%NA
BUY$61.6B-61.21%-7.98-12.57%NA
BUY$82.3B21.91%19.984.86%0.44%

Stock Returns calculator for Northwest Biotherapeutics Stock including INR - Dollar returns

The Northwest Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 10Y

Northwest Biotherapeutics investment value today

Current value as on today

₹69,226

Returns

-₹30,774

(-30.77%)

Returns from Northwest Biotherapeutics Stock

-₹35,849 (-35.85%)

Dollar Impact

₹5,075 (+5.08%)

Indian Investors' Interest in Northwest Biotherapeutics Stock

Search interest for Northwest Biotherapeutics Stock has decreased by -26% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-26% versus previous 30 day period

Northwest Biotherapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-15
-17
-14
-18
-17
-14
-14
-13
-10
-11
EBITDA
-16
-15
-16
-25
-17
-13
-24
-12
-10
-10
Interest Expense
1
1
2
2
1
1
2
2
2
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-18
-17
-19
-28
-19
-15
-26
0
-3
-9
Income Tax Expense
-
-
-
-
-
-
-
0
-
-
Net Income
-18
-17
-19
-28
-19
-15
-26
1
-3
-9
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
-160.50%
-19.20%
-71.46%
-5.58%

Northwest Biotherapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
2
1
1
1
1
1
1
Gross Profit
-33
-17
-11
-32
-19
0
-25
1
0
Operating Income
-54
-41
-27
-86
-52
-67
-55
-66
-59
EBITDA
-67
-24
-17
-520
184
-97
-55
-73
-49
Interest Expense
5
9
2
8
5
6
5
7
-8
Depreciation
0
1
0
0
0
1
1
2
2
Income Before Tax
-73
-35
-20
-529
179
-105
-62
-83
-60
Income Tax Expense
-
-
3
-
-
-
-
-
0
Net Income
-73
-35
-20
-529
179
-105
-62
-83
-61
Net Profit Margin
-9874.70%
-4306.31%
-485.31%
-2505.50%
-1920.70%
8.02%
-1335.30%
100.00%
-69.59%

Northwest Biotherapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-18
-17
-19
-28
-19
-15
-26
1
-3
-8
Operating Cash Flow
-12
-16
-8
-20
-9
-6
-13
-14
-12
-7
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
12
17
11
15
11
12
11
13
9
7
Change in Cash
0
0
0
0
0
1
0
-1
-1
-1

Northwest Biotherapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-73
-35
-20
-529
179
-105
-62
-83
-60
Operating Cash Flow
-36
-34
-31
-32
-38
-52
-53
-57
-44
Investing Cash Flow
0
45
0
-8
-6
-2
-3
-1
-1
Financing Cash Flow
34
7
9
52
48
41
52
56
49
Change in Cash
-6
22
-21
9
5
-8
-4
0
0

Insights on Northwest Biotherapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 537.7% return, outperforming this stock by 574.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 37.1% return, outperforming this stock by 107.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, NWBO stock has moved down by -70.5%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 672.0K → 494.0K (in $), with an average decrease of 26.5% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 1.38M → -3.06M (in $), with an average decrease of 321.1% per quarter

About Northwest Biotherapeutics

Northwest Biotherapeutics, Inc., a biotechnology company, engages in the development of personalized immune therapies for cancer. The company develops DCVax, a platform technology which uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. It also engages in the development of its lead product candidate DCVax-L in Phase III trials for glioblastoma multiforme brain cancer. In addition, the company develops DCVax-Direct in Phase I trials to treat inoperable solid tumors. Northwest Biotherapeutics, Inc. was founded in 1996 and is headquartered in Bethesda, Maryland.
OrganisationNorthwest Biotherapeutics
Headquarters4800 Montgomery Lane, Bethesda, MD, United States, 20814
IndustryBiotechnology
CEOMs. Linda F. Powers J.D.
E-voting on sharesClick here to vote

Key Management of Northwest Biotherapeutics

Name

Title

Ms. Linda F. Powers J.D.

Chairperson, CEO, President, CFO & Chief Accounting Officer

Dr. Alton L. Boynton Ph.D.

Founder, Chief Scientific Officer, Secretary & Director

Dr. Marnix L. Bosch M.B.A., Ph.D.

Chief Technical Officer

Mr. David Innes

Vice President of Investor Relations

FAQs

What is Northwest Biotherapeutics share price today?

Northwest Biotherapeutics share price today is $0.17 as on at the close of the market. Northwest Biotherapeutics share today touched a day high of $0.17 and a low of $0.17.

What is the 52 week high and 52 week low for Northwest Biotherapeutics share?

Northwest Biotherapeutics share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Northwest Biotherapeutics stock price today i.e. is closed at $0.17,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Northwest Biotherapeutics's market capitalisation today?

Northwest Biotherapeutics market capitalisation is $0.00T as on .

How to invest in Northwest Biotherapeutics Stock (NWBO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Northwest Biotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Northwest Biotherapeutics Shares that will get you 8.8235 shares as per Northwest Biotherapeutics share price of $0.17 per share as on September 2, 2026 at 1:29 am IST.

What is the minimum amount required to buy Northwest Biotherapeutics Stock (NWBO) from India?

Indian investors can start investing in Northwest Biotherapeutics (NWBO) shares with as little as ₹94.96 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Northwest Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Northwest Biotherapeutics share’s latest price of $0.17 as on September 2, 2026 at 1:29 am IST, you will get 58.8235 shares of Northwest Biotherapeutics. Learn more about fractional shares .